Pyoderma gangrenosum associated with cystic acne and hidradenitis suppurativa controlled by adding minocycline and sulfasalazine to the treatment regimen.
Pyoderma gangrenosum often presents a difficult therapeutic challenge. The case is described of a 42-year-old black man with the association of cystic acne, hidradenitis suppurativa, and seronegative arthritis with pyoderma gangrenosum. The pyoderma gangrenosum ulcers remained refractory to treatment until therapies aimed in part at the associated diseases were begun. Minocycline was given for treatment of cystic acne and hidradenitis suppurativa as well as pyoderma gangrenosum. Sulfasalazine was prescribed for seronegative arthritis as well as pyoderma gangrenosum. The combination therapy permitted healing of the pyoderma gangrenosum ulcers.
Shenefelt
P D
PD
Department of Internal Medicine, College of Medicine, University of South Florida, Tampa 33612, USA.
D000152:Acne Vulgaris / Q000188:drug therapy*; D000328:Adult; D001168:Arthritis / Q000188:drug therapy*; D003560:Cysts / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D017497:Hidradenitis Suppurativa / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008911:Minocycline / Q000008:administration & dosage*; D017511:Pyoderma Gangrenosum / Q000188:drug therapy*; D012460:Sulfasalazine / Q000008:administration & dosage*; D016896:Treatment Outcome
D012460:Sulfasalazine; D008911:Minocycline